Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

Josh Canavan, PharmD, head of pharmacy at RazorMetrics, and Chris O'Dell, senior vice president of market solutions at Turquoise Health, discuss how the health care system must overcome patient ...

To read all of these articles and more, visit centerforbiosimilars.com.

Pediatric IBD is becoming increasingly common, with an incidence of about 10 cases per 100,000 children in the US and Canada and a rising trend. 2 In the US alone, IBD prevalence ranges from 100 to ...

Alvotech and Advanz Pharma have announced a positive Committee for Medicinal Products for Human Use (CHMP) opinion for their aflibercept biosimilar, AVT06, aiming for European approval. Concurrently, ...